---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-011542"
form_type: "8-K"
ticker: "AZTA"
cik: "0000933974"
company_name: "Azenta, Inc."
filed_at: "2026-04-07T23:59:59+00:00"
generated_at: "2026-05-15T07:12:17.003505+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Azenta appoints Trey Martin as Multiomics President; Ginger Zhou steps down

## Summary
- Trey Martin appointed President of Multiomics effective April 6, 2026; reports to CEO John Marotta.
- Martin most recently served as CEO of Maravai LifeSciences (MRVI) and previously led IDT under Danaher (DHR).
- Ginger Zhou stepped down as President; she will remain as advisor through November 2026 under a consulting agreement with $103,500 initial fee.
- Executive officers Lawrence Lin, Ephraim Starr, and Olga Pirogova received amended offer letters clarifying severance and change-in-control terms.
- Azenta aims to accelerate Multiomics long-range plan focusing on global synthesis scale, operational excellence, and profitable growth.

## SEC filing metadata
- accession: 0001437749-26-011542
- form_type: 8-K
- ticker: AZTA
- cik: 0000933974
- company_name: Azenta, Inc.
- filed_at: 2026-04-07T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/933974/000143774926011542/0001437749-26-011542-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/933974/000143774926011542/azta20260407_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-011542
- JSON: https://secwatch.observer/filing/0001437749-26-011542.json
- Plain text: https://secwatch.observer/filing/0001437749-26-011542.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.